Vascular rejection episodes reduce success in renal graft outcome after therapy with BMA 031.
Hillebrand
G
G
Department of Surgery, Klinikum Grosshadern, München, FRG.
Dendorfer
U
U
Feucht
H E
HE
Brockmeyer
C
C
Gokel
J M
JM
Illner
W D
WD
Abendroth
D
D
Kasper
C
C
Land
W
W
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001808:Blood Vessels / Q000276:immunology; D004730:Endothelium, Vascular / Q000276:immunology; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods* / Q000473:pathology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D012307:Risk Factors; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D007518:Isoantibodies; D011948:Receptors, Antigen, T-Cell